Anatomy of a Drug Manufacturing Plant (Part 2 in a Three-Part Series Examining the Financial Impact of New Plant Construction)

SUGAR LAND--July 27, 2015--Reported by Annette Kreuger, Industrial Info Resources, (Sugar Land, Texas)--As the actual construction begins on a new pharmaceutical or biotech plant, the positive financial impact continues to resonate across an incredible number of companies. For illustrative purposes, this brief will focus on Novo Nordisk's (NYSE:NVO) (Bagsværd, Denmark) $1.8 billion planned active pharmaceutical ingredient (API) production plant in Clayton, Johnson County, North Carolina.

Within this article: Mentions how many jobs the project will create